Biogen Pharmachem Industries Ltd
NSE: BSE: 531752
₹0.54
(0%)
Sun, 22 Mar 2026, 05:57 am
Market Cap487.41M
PE Ratio16.56
Dividend0
Finance
Investment Banks/Brokers
24.5KBiogen Pharmachem Industries Income Statement
| Particulars | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 85.10M | 1.57B | 18.82M | 651.53K | 3.35B | 0 | -40.00K | -43.71K | 0 | -266.74K | -64.69M | 9.50M | -2.50K | 144.69K | 21.69M | 9.13M | 23.81M | 8.38M |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — | — | 399.00K | -784.07K | -14.66M | 1.13M | 7.99M | 21.20M | 5.32M |
| Operating expenses (excl. COGS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling/general/admin expenses, total | — | — | — | — | — | — | — | — | — | — | — | — | -66.00K | -22.90K | -1.23M | -588.80K | -1.35M | -941.00K | -1.53M |
| Research & development | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling/general/admin expenses, other | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other operating expenses, total | 0 | -85.10M | — | -18.88M | -386.78K | -3.35B | -361.69K | -285.48K | -310.64K | -244.60K | -939.49K | -926.39K | -368.00K | -360.00K | -139.00K | -626.77K | -2.08M | -951.00K | -6.72M |
| Operating income | — | — | -42.67M | -66.61K | -709.92K | -950.04K | -1.33M | -1.30M | -1.33M | -281.76K | -1.21M | -65.62M | -35.00K | -1.17M | -16.03M | -84.14K | 4.56M | 19.31M | -2.93M |
| Non-operating income, total | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest expense, net of interest capitalized | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest capitalized | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Non-operating income, excl. interest expenses | 5.51M | -2.44M | -663.55K | 0 | -823.89K | 0 | -5.27K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating interest income | — | — | — | — | — | — | — | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Miscellaneous non-operating expense | 5.51M | -2.44M | -663.55K | 0 | -823.89K | 0 | -5.27K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Unusual income/expense | — | — | — | — | — | — | — | — | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 |
| Pretax income | 5.51M | -2.44M | -43.33M | -66.61K | -1.53M | -950.04K | -1.34M | -1.30M | -1.33M | -281.76K | -1.21M | -65.62M | -35.48K | -1.17M | -16.03M | -85.94K | 4.55M | 19.31M | -2.93M |
| Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 5.51M | -2.44M | -43.33M | -66.61K | -1.53M | -950.04K | -1.34M | -1.30M | -1.33M | -281.76K | -1.21M | -65.62M | -35.48K | -1.17M | -16.03M | -85.94K | 4.55M | 19.31M | -2.93M |
| Net income | 5.51M | -2.44M | -43.33M | -66.61K | -1.53M | -950.04K | -1.34M | -1.30M | -1.33M | -281.76K | -1.21M | -65.62M | -35.48K | -1.17M | -16.03M | -85.94K | 4.55M | 19.31M | -2.93M |
| Dilution adjustment | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | — | — | -42.67M | -66.61K | 264.75K | 24.62K | -361.69K | -330.86K | -359.57K | -250.48K | -1.21M | -65.62M | — | -1.17M | -16.03M | -84.13K | 4.56M | 19.31M | -2.93M |
| EBIT | — | — | -42.67M | -66.61K | -709.92K | -950.04K | -1.33M | -1.30M | -1.33M | -281.76K | -1.21M | -65.62M | -35.00K | -1.17M | -16.03M | -84.13K | 4.56M | 19.31M | -2.93M |
| Total operating expenses | 0 | -85.10M | -1.61B | -18.88M | -1.36M | -3.36B | -1.33M | -1.26M | -1.28M | -281.76K | -939.49K | -927.04K | -9.53M | -1.16M | -16.18M | -21.77M | -4.57M | -4.51M | -11.31M |
| Prepaid expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Deferred income, current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Capital and operating lease obligations | 0 | 0 | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating lease liabilities | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Deferred tax liabilities | 15.88M | 15.88M | 15.88M | 15.88M | 15.88M | 15.88M | 15.88M | 15.88M | 15.88M | 15.88M | 15.88M | 15.88M | 15.88M | — | — | — | — | — | — |
| Deferred income, non-current | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Preferred dividends paid | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800